Studies have demonstrated that PRDX3 expression is particularly elevated in CSC-enriched populations, such as CD133+ colon cancer stem cells, where it facilitates tumor progression and metastasis [53]. This evidence concerns the gene PRDX3 and malignant colon neoplasm.